Therapeutic Uses
Antiretroviral / Anti-HIV
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
Tenofovir soproxil dimer,Tenofovir Disoproxil Fumarate IP Impurity F
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
Tenofovir Mono POC Dimer is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Tenofovir Mono POC Dimer usage and description
Tenofovir Mono POC Dimer is a novel antiviral drug that has been developed for the treatment of HIV infection. This drug is a prodrug of tenofovir, a widely used antiretroviral drug. Tenofovir Mono POC Dimer is designed to be more effective than tenofovir by improving its bioavailability and reducing toxicity.
The chemical structure of Tenofovir Mono POC Dimer is a dimer of tenofovir monophosphate, which is the active metabolite of tenofovir. This dimer is linked by a phosphate ester bond and has a POC (propyloxy-carbonyl) group attached to the phosphate ester. The POC group serves as a prodrug moiety that facilitates the delivery of tenofovir monophosphate to the site of action.
Tenofovir Mono POC Dimer is administered orally and is rapidly absorbed into the bloodstream. Once inside the body, the POC group is cleaved by esterases, releasing tenofovir monophosphate. This active metabolite then inhibits the reverse transcriptase enzyme of HIV, preventing viral replication and reducing the viral load in the body.
Tenofovir Mono POC Dimer has been shown to be effective in reducing viral load in clinical trials. It has also been found to have a favorable safety profile, with fewer adverse effects compared to tenofovir. This drug has the potential to become an important addition to the armamentarium of antiretroviral drugs for the treatment of HIV infection.
